Agrawal Meenal G, Bhanushali Aparna A, Dedhia Pratiksha, Jeswani Kanchan D, Dayanand Sucheta, Dasgupta Amar, Das Bibhu R
Research and Development, SRL Ranbaxy Ltd, MIDC, Mumbai, India.
Eur J Haematol. 2007 Sep;79(3):248-50. doi: 10.1111/j.1600-0609.2007.00896.x. Epub 2007 Jul 26.
The present report describes the hematologic and molecular study of the second case of Hb D(Iran) associated with beta(0)-thalassemia (619 bp-deletion) found in India and the first case in which the mutations have been identified at molecular level. The patient showed hypochromic, microcytic red cell picture with reduced red cell indices. The characterization of the hemoglobinopathy was made by electrophoretic and chromatographic techniques and confirmed by sequencing of the beta-globin gene. Both the propositus and her father were found to be carriers of the gene for beta(0)-thalassemia owing to the 619 bp-deletion mutation as seen by the polymerase chain reaction (PCR). Single base substitution GAA > CAA (indicative of Hb D(Iran)) in the heterozygous form was seen in the propositus as well as the mother by sequencing.
本报告描述了在印度发现的第二例与β⁰-地中海贫血(619 bp缺失)相关的Hb D(伊朗型)病例的血液学和分子研究,这也是首例在分子水平鉴定出突变的病例。患者呈现低色素、小细胞红细胞图像,红细胞指数降低。通过电泳和色谱技术对血红蛋白病进行了表征,并通过β-珠蛋白基因测序得到证实。通过聚合酶链反应(PCR)发现,先证者及其父亲均因619 bp缺失突变而成为β⁰-地中海贫血基因的携带者。通过测序发现,先证者及其母亲均存在杂合形式的单碱基替换GAA > CAA(提示Hb D(伊朗型))。